Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$992,014
+$886,595 QoQ
Shares Held
608,601
+841.0% QoQ
Ownership
0.670%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,550,634,982 across 214 Biotechnology names. CDXS ranks #127 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in CDXS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $992,014 | 608,601 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $105,419 | 64,675 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $205,127 | 84,069 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $206,316 | 84,556 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $209,905 | 78,032 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $494,318 | 103,631 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $968,535 | 314,460 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $735,541 | 237,272 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $453,933 | 130,067 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $576,354 | 188,969 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,349,210 | 713,868 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,145,528 | 766,260 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,017,277 | 487,265 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,029,957 | 221,021 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $886,565 | 146,298 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $231,845 | 22,165 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,404,490 | 68,113 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $727,777 | 23,274 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $184,024 | 15,675 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||